Although FLT3‐ITD mutations were not significantly associated with VSIR expression, since they occur in roughly 20%–25% of AML cases,34 it is of importance to study the prognostic value of VSIR within populations with and without the FLT3‐ITD mutation. Here, FLT3 is linked to acute myeloid leukemia.